CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-10 | Smith Michael Alexander General Counsel, Senior VP | Sale | −1,836 | $17.93 | $33K | 54,332 |
| 2023-01-10 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −2,435 | $17.95 | $44K | 72,159 |
| 2023-01-10 | Lewis William Chair and CEO | Sale | −6,994 | $18.00 | $126K | 265,067 |
| 2023-01-10 | Flammer Martina M.D. Chief Medical Officer | Sale | −3,439 | $18.06 | $62K | 72,763 |
| 2023-01-10 | Bonstein Sara Chief Financial Officer | Sale | −2,857 | $18.12 | $52K | 66,031 |
| 2023-01-10 | Adsett Roger Chief Operating Officer | Sale | −3,194 | $17.99 | $57K | 135,487 |
| 2023-01-05 | Wise John Drayton Chief Commercial Officer | Sale | −1,160 | $19.74 | $23K | 70,453 |
| 2023-01-05 | Wise John Drayton Chief Commercial Officer | Grant or award | +7,598 | 78,051 | ||
| 2023-01-05 | Wise John Drayton Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +34,860 | 34,860 | ||
| 2023-01-05 | Smith Michael Alexander General Counsel, Senior VP | Sale | −720 | $19.72 | $14K | 49,836 |
| 2023-01-05 | Smith Michael Alexander General Counsel, Senior VP | Grant or award | +6,332 | 56,168 | ||
| 2023-01-05 | Smith Michael Alexander General Counsel, Senior VP | Grant or award · Stock Option (right to buy) | +29,050 | 29,050 | ||
| 2023-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale | −1,374 | $19.73 | $27K | 65,058 |
| 2023-01-05 | Flammer Martina M.D. Chief Medical Officer | Grant or award | +7,598 | 72,656 | ||
| 2023-01-05 | Flammer Martina M.D. Chief Medical Officer | Grant or award | +3,546 | 76,202 | ||
| 2023-01-05 | Flammer Martina M.D. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +34,860 | 34,860 | ||
| 2023-01-05 | Adsett Roger Chief Operating Officer | Sale | −3,044 | $19.75 | $60K | 131,083 |
| 2023-01-05 | Adsett Roger Chief Operating Officer | Grant or award | +7,598 | 138,681 | ||
| 2023-01-05 | Adsett Roger Chief Operating Officer | Grant or award · Stock Option (right to buy) | +34,860 | 34,860 | ||
| 2023-01-05 | Bonstein Sara Chief Financial Officer | Grant or award | +8,232 | 63,823 |
Page 49 of 54 · 1,061 trades